StockWatch
·
Biotechnology: Pharmaceutical Preparations
Open OfferMay 29, 2026, 04:39 PM

BullFrog AI Registers 2M Shares for Resale by Lincoln Park

AI Summary

BullFrog AI Holdings, Inc. filed an S-1 registration statement for the resale of up to 2,000,000 shares of common stock by Lincoln Park Capital Fund, LLC. These shares are part of an existing Purchase Agreement, under which BullFrog AI may receive up to an additional $4,099,102 from future sales. The company recently regained compliance with Nasdaq's stockholders' equity requirement but faces a potential delisting due to its stock price falling below $1.00. Additionally, BullFrog AI entered a feasibility agreement with a global pharmaceutical company for drug target discovery using its bfLEAP® AI/ML platform.

Key Highlights

  • Registers 2,000,000 common shares for resale by Lincoln Park Capital Fund.
  • May receive up to $4,099,102 from future sales to Lincoln Park.
  • Regained Nasdaq stockholders' equity compliance as of April 21, 2026.
  • Received Nasdaq bid price non-compliance notice on February 10, 2026.
  • Entered one-year feasibility agreement for MDD drug target discovery.
  • Auditor expressed substantial doubt about going concern in 2025 10-K.